Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chemotherapy Regimen

Known as: cancer pharmacotherapy, neoplasm chemotherapy, chemo 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
National Comprehensive Cancer Network (NCCN) guidelines represent the consensus standard of care for diagnosis and management of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2017
Highly Cited
2017
BACKGROUND Atezolizumab is a humanised antiprogrammed death-ligand 1 (PD-L1) monoclonal antibody that inhibits PD-L1 and… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Nivolumab, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, can result in durable responses in patients… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND We conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal growth factor… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND We conducted a randomized study to determine whether any of three chemotherapy regimens was superior to cisplatin and… Expand
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
A BSTRACT Background We conducted a randomized study to determine whether any of three chemotherapy regimens was superior to… Expand
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND AND METHODS On behalf of the Gynecologic Oncology Group, we performed a randomized trial of radiotherapy in… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE Overexpression of the HER2 protein occurs in 25% to 30% of human breast cancers and leads to a particularly aggressive… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… Expand
Is this relevant?